Genitourinary Cancers

Elizabeth Plimack MD MS reviews key genitourinary cancer findings presented at the 2017 American Society of Clinical Oncology Annual Meeting.

Share

Program Content

Activities

  • KEYNOTE-052: Pembro in UC
    KEYNOTE-052: Updated Findings on First-line Pembrolizumab in Cisplatin-Ineligible Advanced Urothelial Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2017

    Expires: June 07, 2018

  • ECHO-202: Epacadostat in RCC
    ECHO-202/KEYNOTE-037: Phase I/II Study of Epacadostat + Pembrolizumab in Pts With Advanced RCC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2017

    Expires: June 07, 2018

  • KEYNOTE-045: Pembro vs CT in mUC
    KEYNOTE-045: Updated Survival Analysis of Phase III Trial of Pembrolizumab vs Paclitaxel, Docetaxel, or Vinflunine in Pts With Advanced Urothelial Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2017

    Expires: June 08, 2018

  • PROTECT: Adjuvant Pazopanib
    PROTECT: Adjuvant Pazopanib After Nephrectomy in Pts With Locally Advanced RCC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 13, 2017

    Expires: June 12, 2018

  • ECHO-202/KEYNOTE-037
    Phase Ib/II ECHO-202/KEYNOTE-037: Epacadostat + Pembrolizumab in Pts With Advanced Urothelial Carcinoma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 14, 2017

    Expires: June 13, 2018

Provided by

ProCE Banner

Supporters

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology